<DOC>
	<DOC>NCT02519088</DOC>
	<brief_summary>The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany. A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy. The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.</brief_summary>
	<brief_title>A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)</brief_title>
	<detailed_description>Retrospective audit of 470 consecutive primary THA in 2013 and 2014</detailed_description>
	<criteria>primary THA on patients with coxarthrosis any kind of old or acute fractures about the basin and hip combined surgery, like first extracting a femur nail and than undergoing THA any other kind of combined or simultaneous surgery any kind of coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Homologous Blood Transfusion</keyword>
	<keyword>Total Hip Replacement</keyword>
	<keyword>Patient Blood Management</keyword>
</DOC>